Skip to main content Accessibility help

Effect of selenium on markers of risk of pre-eclampsia in UK pregnant women: a randomised, controlled pilot trial

  • Margaret P. Rayman (a1), Elizabeth Searle (a2), Lynne Kelly (a3), Sigurd Johnsen (a4), Katherine Bodman-Smith (a1), Sarah C. Bath (a1), Jinyuan Mao (a1) and Christopher W. G. Redman (a2)...


Pre-eclampsia is a serious hypertensive condition of pregnancy associated with high maternal and fetal morbidity and mortality. Se intake or status has been linked to the occurrence of pre-eclampsia by our own work and that of others. We hypothesised that a small increase in the Se intake of UK pregnant women of inadequate Se status would protect against the risk of pre-eclampsia, as assessed by biomarkers of pre-eclampsia. In a double-blind, placebo-controlled, pilot trial, we randomised 230 primiparous pregnant women to Se (60 μg/d, as Se-enriched yeast) or placebo treatment from 12 to 14 weeks of gestation until delivery. Whole-blood Se concentration was measured at baseline and 35 weeks, and plasma selenoprotein P (SEPP1) concentration at 35 weeks. The primary outcome measure of the present study was serum soluble vascular endothelial growth factor receptor-1 (sFlt-1), an anti-angiogenic factor linked with the risk of pre-eclampsia. Other serum/plasma components related to the risk of pre-eclampsia were also measured. Between 12 and 35 weeks, whole-blood Se concentration increased significantly in the Se-treated group but decreased significantly in the placebo group. At 35 weeks, significantly higher concentrations of whole-blood Se and plasma SEPP1 were observed in the Se-treated group than in the placebo group. In line with our hypothesis, the concentration of sFlt-1 was significantly lower at 35 weeks in the Se-treated group than in the placebo group in participants in the lowest quartile of Se status at baseline (P= 0·039). None of the secondary outcome measures was significantly affected by treatment. The present finding that Se supplementation has the potential to reduce the risk of pre-eclampsia in pregnant women of low Se status needs to be validated in an adequately powered trial.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Effect of selenium on markers of risk of pre-eclampsia in UK pregnant women: a randomised, controlled pilot trial
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Effect of selenium on markers of risk of pre-eclampsia in UK pregnant women: a randomised, controlled pilot trial
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Effect of selenium on markers of risk of pre-eclampsia in UK pregnant women: a randomised, controlled pilot trial
      Available formats


The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution licence

Corresponding author

* Corresponding author: Professor M. P. Rayman, fax +44 1483 686401, email


Hide All
1 Duley, L (2009) The global impact of pre-eclampsia and eclampsia. Semin Perinatol 33, 130137.
2 Wilson, BJ, Watson, MS, Prescott, GJ, et al. (2003) Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 326, 845851.
3 Bellamy, L, Casas, JP, Hingorani, AD, et al. (2007) Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335, 974985.
4 Levine, RJ, Vatten, LJ, Horowitz, GL, et al. (2009) Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case–control and population based study. BMJ 339, b4336.
5 Redman, CW & Sargent, IL (2000) Placental debris, oxidative stress and pre-eclampsia. Placenta 21, 597602.
6 Hubel, CA (1999) Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 222, 222235.
7 Burton, GJ & Jauniaux, E (2004) Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig 11, 342352.
8 Vanderlelie, J, Venardos, K, Clifton, VL, et al. (2005) Increased biological oxidation and reduced anti-oxidant enzyme activity in pre-eclamptic placentae. Placenta 26, 5358.
9 Burton, GJ, Yung, HW, Cindrova-Davies, T, et al. (2009) Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta 30, S43S48.
10 Hung, TH, Skepper, JN, Charnock-Jones, DS, et al. (2002) Hypoxia–reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res 90, 12741281.
11 Maynard, SE, Min, JY, Merchan, J, et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111, 649658.
12 Levine, RJ, Maynard, SE, Qian, C, et al. (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350, 672683.
13 Venkatesha, S, Toporsian, M, Lam, C, et al. (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12, 642649.
14 Daniel, Y, Kupferminc, MJ, Baram, A, et al. (1999) A selective increase in plasma soluble vascular cell adhesion molecule-1 levels in preeclampsia. Am J Reprod Immunol 41, 407412.
15 Austgulen, R, Lien, E, Vince, G, et al. (1997) Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E-selectin) in preeclampsia. Eur J Obstet Gynecol Reprod Biol 71, 5358.
16 Arteel, GE, Briviba, K & Sies, H (1999) Protection against peroxynitrite. FEBS Lett 445, 226230.
17 Myatt, L, Rosenfield, RB, Eis, AL, et al. (1996) Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension 28, 488493.
18 Roggensack, AM, Zhang, Y & Davidge, ST (1999) Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension 33, 8389.
19 Cockell, AP, Learmont, JG, Smárason, AK, et al. (1997) Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function. Br J Obstet Gynaecol 104, 235240.
20 Goswami, D, Tannetta, DS, Magee, LA, et al. (2006) Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta 27, 5661.
21 Redman, CW, Sacks, GP & Sargent, IL (1999) Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 180, 499506.
22 Roberts, JM, Taylor, RN, Musci, TJ, et al. (1989) Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161, 12001204.
23 Rayman, MP (2011) Selenium and adverse conditions of human pregnancy. In Selenium: Its Molecular Biology and Role in Human Health, 3rd ed., pp. 531546 [Hatfield, DL, Berry, MJ and Gladyshev, VN, editors]. New York: Springer Science+Business Media, LLC.
24 Rayman, MP (2012) Selenium and human health. Lancet 379, 12561268.
25 Brigelius-Flohé, R, Banning, A & Schnurr, K (2003) Selenium-dependent enzymes in endothelial cell function. Antioxid Redox Signal 5, 205215.
26 Lewin, MH, Arthur, JR, Riemersma, RA, et al. (2002) Selenium supplementation acting through the induction of thioredoxin reductase and glutathione peroxidase protects the human endothelial cell line EAhy926 from damage by lipid hydroperoxides. Biochim Biophys Acta 1593, 8592.
27 Gao, Y, Hannan, NR, Wanyonyi, S, et al. (2006) Activation of the selenoprotein SEPS1 gene expression by pro-inflammatory cytokines in HepG2 cells. Cytokine 33, 246251.
28 Ejima, K, Layne, MD, Carvajal, IM, et al. (2002) Modulation of the thioredoxin system during inflammatory responses and its effect on heme oxygenase-1 expression. Antioxid Redox Signal 4, 569575.
29 Trigona, WL, Mullarky, IK, Cao, Y, et al. (2006) Thioredoxin reductase regulates the induction of haem oxygenase-1 expression in aortic endothelial cells. Biochem J 394, 207216.
30 Vanderlelie, JJ & Perkins, AV (2011) Selenium and preeclampsia: a global perspective. Pregnancy Hypertens 1, 213224.
31 Han, L & Zhou, SM (1994) Selenium supplement in the prevention of pregnancy induced hypertension. Chin Med J (Engl) 107, 870871.
32 Atamer, Y, Koçyigit, Y, Yokus, B, et al. (2005) Lipid peroxidation, antioxidant defense, status of trace metals and leptin levels in preeclampsia. Eur J Obstet Gynecol Reprod Biol 119, 6066.
33 Chamy, VM, Lepe, J, Catalán, A, et al. (2006) Oxidative stress is closely related to clinical severity of pre-eclampsia. Biol Res 39, 229236.
34 Mistry, HD, Wilson, V, Ramsay, MM, et al. (2008) Reduced selenium concentrations and glutathione peroxidase activity in preeclamptic pregnancies. Hypertension 52, 881888.
35 Maleki, A, Fard, MK, Zadeh, DH, et al. (2011) The relationship between plasma level of Se and preeclampsia. Hypertens Pregnancy 30, 180187.
36 Ghaemi, SZ, Forouhari, S, Dabbaghmanesh, MH, et al. (2013) A prospective study of selenium concentration and risk of preeclampsia in pregnant Iranian women: a nested case–control study. Biol Trace Elem Res 152, 174179.
37 Walsh, SW & Wang, Y (1993) Deficient glutathione peroxidase activity in preeclampsia is associated with increased placental production of thromboxane and lipid peroxides. Am J Obstet Gynecol 169, 14561461.
38 Moses, EK, Johnson, MP, Tømmerdal, L, et al. (2008) Genetic association of preeclampsia to the inflammatory response gene SEPS1. Am J Obstet Gynecol 198, 336e1336e5.
39 Vanderlelie, J, Venardos, K & Perkins, AV (2004) Selenium deficiency as a model of experimental pre-eclampsia in rats. Reproduction 128, 635641.
40 Rayman, MP, Abou-Shakra, FR, Ward, NI, et al. (1996) Comparison of selenium levels in pre-eclamptic and normal pregnancies. Biol Trace Elem Res 55, 920.
41 Rayman, MP, Bode, P & Redman, CWG (2003) Low selenium status is associated with the occurrence of the pregnancy disease preeclampsia in women from the United Kingdom. Am J Obstet Gynecol 189, 13431349.
42 Department of Health (1991) Dietary reference values for food, energy and nutrients for the United Kingdom. Report of the Panel on Dietary Reference Values of the Committee on Medical Aspects of Food Policy (COMA). Rep Health Soc Subj (Lond) 41, 1210.
43 Tidwell, SC, Ho, HN, Chiu, WH, et al. (2001) Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 184, 12671272.
44 Levine, RJ, Lam, C, Qian, C, et al. (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355, 9921005.
45 Muttukrishna, S, North, RA, Morris, J, et al. (2000) Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Hum Reprod 15, 16401645.
46 Anim-Nyame, N, Gamble, J, Sooranna, SR, et al. (2003) Evidence of impaired microvascular function in pre-eclampsia: a non-invasive study. Clin Sci (Lond) 104, 405412.
47 García, RG, Celedón, J, Sierra-Laguado, J, et al. (2007) Raised C-reactive protein and impaired flow-mediated vasodilation precede the development of preeclampsia. Am J Hypertens 20, 98103.
48 Dubin, R, Li, Y, Ix, JH, et al. (2012) Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study. Am Heart J 163, 274279.
49 Burk, RF & Hill, KE (2009) Selenoprotein P – expression, functions, and roles in mammals. Biochim Biophys Acta 1790, 14411447.
50 Sloth, JJ & Larsen, EH (2000) The application of ICP dynamic reaction cell mass spectrometry for measurement of selenium isotopes, isotope ratios and chromatographic detection of selenoamino acids. J Anal Atom Spectrom 15, 669672.
51 Sieniawska, C, Meniskov, R & Delves, HT (1999) Determination of total selenium in serum, whole blood and erythrocytes by ICP-MS. J Anal Atom Spectrom 14, 109112.
52 Burk, RF, Norsworthy, BK, Hill, KE, et al. (2006) Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial. Cancer Epidemiol Biomarkers Prev 15, 804810.
53 Tannetta, DS, Muttukrishna, S, Groome, NP, et al. (2003) Endothelial cells and peripheral blood mononuclear cells are a potential source of extraplacental activin A in preeclampsia. J Clin Endocrinol Metab 88, 59956001.
54 Gillespie, SH, Dow, C, Raynes, JG, et al. (1991) Measurement of acute phase proteins for assessing severity of Plasmodium falciparum malaria. J Clin Pathol 44, 228231.
55 Ross, MG & Idah, R (2004) Correlation of maternal plasma volume and composition with amniotic fluid index in normal human pregnancy. J Matern Fetal Neonatal Med 15, 104108.
56 Behne, D, Alber, D & Kyriakopoulos, A (2010) Long-term selenium supplementation of humans: selenium status and relationships between selenium concentrations in skeletal muscle and indicator materials. J Trace Elem Med Biol 24, 99105.
57 Whittaker, PG & Lind, T (1993) The intravascular mass of albumin during human pregnancy: a serial study in normal and diabetic women. Br J Obstet Gynaecol 100, 587592.
58 Davey, DA & MacGillivray, I (1988) The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 158, 892898.
59 Rana, S, Powe, CE, Salahuddin, S, et al. (2012) Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 125, 911919.
60 Saudan, P, Brown, MA, Buddle, ML, et al. (1998) Does gestational hypertension become pre-eclampsia? Br J Obstet Gynaecol 105, 11771184.
61 Brown, MA & de Swiet, M (1999) Classification of hypertension in pregnancy. Baillieres Best Pract Res Clin Obstet Gynaecol 13, 2739.
62 Barton, JR, O'Brien, JM, Bergauer, NK, et al. (2001) Mild gestational hypertension remote from term: progression and outcome. Am J Obstet Gynecol 184, 979983.
63 Davis, GK, Mackenzie, C, Brown, MA, et al. (2007) Predicting transformation from gestational hypertension to preeclampsia in clinical practice: a possible role for 24 hour ambulatory blood pressure monitoring. Hypertens Pregnancy 26, 7787.
64 Butler, JA, Whanger, PD & Tripp, MJ (1982) Blood selenium and glutathione peroxidase activity in pregnant women: comparative assays in primates and other animals. Am J Clin Nutr 36, 1523.
65 Zachara, BA, Wardak, C, Didkowski, W, et al. (1993) Changes in blood selenium and glutathione concentrations and glutathione peroxidase activity in human pregnancy. Gynecol Obstet Invest 35, 1217.
66 Burk, RF, Olson, GE, Hill, KE, et al. (2013) Maternal–fetal transfer of selenium in the mouse. FASEB J 27, 32493256.
67 Vunta, H, Davis, F, Palempalli, UD, et al. (2007) The anti-inflammatory effects of selenium are mediated through 15-deoxy-Δ12,14-prostaglandin J2 in macrophages. J Biol Chem 282, 1796417973.
68 Vunta, H, Belda, BJ, Arner, RJ, et al. (2008) Selenium attenuates pro-inflammatory gene expression in macrophages. Mol Nutr Food Res 52, 13161323.
69 Bainbridge, SA & Smith, GN (2005) HO in pregnancy. Free Radic Biol Med 38, 979988.
70 Cudmore, M, Ahmad, S, Al-Ani, B, et al. (2007) Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 115, 17891797.
71 Kirkby, KA & Adin, CA (2006) Products of heme oxygenase and their potential therapeutic applications. Am J Physiol Renal Physiol 290, F563F571.
72 Ahmed, A, Rahman, M, Zhang, X, et al. (2000) Induction of placental heme oxygenase-1 is protective against TNFalpha-induced cytotoxicity and promotes vessel relaxation. Mol Med 6, 391409.
73 Traulsen, H, Steinbrenner, H, Buchczyk, DP, et al. (2004) Selenoprotein P protects low-density lipoprotein against oxidation. Free Radic Res 38, 123128.
74 Thomson, CD, Robinson, MF, Butler, JA, et al. (1993) Long-term supplementation with selenate and selenomethionine: selenium and glutathione peroxidase (EC in blood components of New Zealand women. Br J Nutr 69, 577588.
75 Hurst, R, Armah, CN, Dainty, JR, et al. (2010) Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 91, 923931.
76 Kimmons, JE, Blanck, HM, Tohill, BC, et al. (2006) Associations between body mass index and the prevalence of low micronutrient levels among US adults. MedGenMed 8, 59.
77 Arnaud, J, Bertrais, S, Roussel, AM, et al. (2006) Serum selenium determinants in French adults: the SU.VI.M.AX study. Br J Nutr 95, 313320.
78 Méplan, C, Crosley, LK, Nicol, F, et al. (2007) Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study). FASEB J 21, 30633074.
79 Bodnar, LM, Tang, G, Ness, RB, et al. (2006) Periconceptional multivitamin use reduces the risk of preeclampsia. Am J Epidemiol 164, 470477.
80 Rayman, MP (2008) Food-chain selenium and human health: emphasis on intake. Br J Nutr 100, 254268.


Related content

Powered by UNSILO

Effect of selenium on markers of risk of pre-eclampsia in UK pregnant women: a randomised, controlled pilot trial

  • Margaret P. Rayman (a1), Elizabeth Searle (a2), Lynne Kelly (a3), Sigurd Johnsen (a4), Katherine Bodman-Smith (a1), Sarah C. Bath (a1), Jinyuan Mao (a1) and Christopher W. G. Redman (a2)...


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.